文献速递骨质疏松与代谢性骨病创伤骨科

私立骨科诊所骨质疏松管理服务降低后续骨折风险的有效性

The Effectiveness of a Private Orthopaedic Practice-Based Osteoporosis Management Service to Reduce the Risk of Subsequent Fractures.
PubMed 文献 · J Bone Joint Surg Am · 2018-01-01

这项回顾性队列研究利用密歇根州100% Medicare数据,比较接受私立骨科诊所骨质疏松管理服务(OP MS)与未接受该服务的骨折患者。倾向评分匹配后各1304例,暴露组后续骨折风险更低(HR=0.8,95%CI=0.7-0.9),骨质疏松药物处方和骨密度评估比例更高,12个月总费用无显著差异。

要点

  • 暴露组后续骨折风险低于未暴露组(HR=0.8,95%CI=0.7-0.9)。
  • 暴露组骨质疏松药物处方可能性更高(HR=1.7,95%CI=1.4-2.0)。
  • 暴露组骨密度评估可能性更高(HR=4.3,95%CI=3.7-5.0)。

核心结论

  • 私立骨科诊所为基础的OP MS有效降低后续骨折风险,可能通过协调和持续的综合患者管理实现,且总体费用无显著增高。

研究设计与样本

  • 回顾性队列研究,使用2010年4月1日至2014年9月30日密歇根州居民100% Medicare数据集,纳入任何椎体、髋部、骨盆或股骨、或其他非椎体骨折患者。
  • 暴露组为首发骨折后90天内接受OP MS随访者,未暴露组为未寻求OP MS但在首发骨折后90天内就诊医师者,首次随访日期为指数日期。
  • 纳入指数前90天持续参加Medicare A和B部分的患者,随访至死亡、退保或研究结束(2014年12月31日)中最早发生者。
  • 采用倾向评分匹配,暴露组与未暴露组在倾向评分±0.01单位内1:1匹配,匹配后各1304例。
  • 匹配后采用Cox回归评估临床和经济结局的风险比(HR)。

主要发现

  • 暴露组后续骨折中位时间长于未暴露组(998天 vs 743天;log-rank p=0.001)。
  • 暴露组后续骨折风险低于未暴露组(HR=0.8;95%CI=0.7-0.9)。
  • 暴露组骨质疏松药物处方可能性高于未暴露组(HR=1.7;95%CI=1.4-2.0)。
  • 暴露组骨密度评估可能性高于未暴露组(HR=4.3;95%CI=3.7-5.0)。
  • 12个月总费用暴露组25306美元 vs 未暴露组22896美元(p=0.082),无显著差异。

关键数值与推荐

  • 暴露组后续骨折风险HR=0.8(95%CI=0.7-0.9)。
  • 暴露组骨质疏松药物处方HR=1.7(95%CI=1.4-2.0)。
  • 暴露组骨密度评估HR=4.3(95%CI=3.7-5.0)。
  • 12个月总费用暴露组25306美元 vs 未暴露组22896美元(p=0.082)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteoporosis is prevalent in the United States, with an increasing need for management. In this study, we evaluated the effectiveness of a private orthopaedic practice-based osteoporosis management service (OP MS) in reducing subsequent fracture risk and improving other aspects of osteoporosis management of patients who had sustained fractures. METHODS: This was a retrospective cohort study using the 100% Medicare data set for Michigan residents with any vertebral; hip, pelvic or femoral; or other nonvertebral fracture during the period of April 1, 2010 to September 30, 2014. Patients who received OP MS care with a follow-up visit within 90 days of the first fracture, and those who did not seek OP MS care but had a physician visit within 90 days of the first fracture, were considered as exposed and unexposed, respectively (first follow-up visit = index date). Eligible patients with continuous enrollment in Medicare Parts A and B for the 90-day pre-index period were followed until the earliest of death, health-plan disenrollment, or study end (December 31, 2014) to evaluate rates of subsequent fracture, osteoporosis medication prescriptions filled, and bone mineral density (BMD) assessments. Health-care costs were evaluated among patients with 12 months of post-index continuous enrollment. Propensity-score matching was used to balance differences in baseline characteristics. Each exposed patient was matched to an unexposed patient within ± 0.01 units of the propensity score. After propensity-score matching, Cox regression examined the hazard ratio (HR) of clinical and economic outcomes in the exposed and unexposed cohorts. RESULTS: Two well-matched cohorts of 1,304 patients each were produced. The exposed cohort had a longer median time to subsequent fracture (998 compared with 743 days; log-rank p = 0.001), a lower risk of subsequent fracture (HR = 0.8; 95% confidence interval [CI] = 0.7 to 0.9), and a higher likelihood of having osteoporosis medication prescriptions filled (HR = 1.7; 95% CI = 1.4 to 2.0) and BMD assessments (HR = 4.3; 95% CI = 3.7 to 5.0). The total 12-month costs ($25,306 compared with $22,896 [USD]; p = 0.082) did not differ significantly between the cohorts. CONCLUSIONS: A private orthopaedic practice-based OP MS effectively reduced subsequent fracture risk, likely through coordinated and ongoing comprehensive patient care, without a significant overall higher cost. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Sietsema DL, Araujo AB, Wang L, et al. The Effectiveness of a Private Orthopaedic Practice-Based Osteoporosis Management Service to Reduce the Risk of Subsequent Fractures. J Bone Joint Surg Am. 2018. PMID: 30399076. doi:10.2106/JBJS.17.01388

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。